menu
    • menu

    Company profile for Kallyope

    NEW Drugs in Dev: 3
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Kallyope, we are developing an industry-leading therapeutic platform based on our comprehensive understanding of gut-brain biology. Founded and headquartered in New York City, our cross-disciplinary team is integrating cutting-edge technologies in sequencing, computational biology, neural imaging, cellular and molecular biology and human genetics to provide an understanding of gut-brain biology that, when coupled with our d...
    At Kallyope, we are developing an industry-leading therapeutic platform based on our comprehensive understanding of gut-brain biology. Founded and headquartered in New York City, our cross-disciplinary team is integrating cutting-edge technologies in sequencing, computational biology, neural imaging, cellular and molecular biology and human genetics to provide an understanding of gut-brain biology that, when coupled with our deep drug discovery expertise, will lead to transformational therapeutics to improve human health.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    KallyopeUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    430 East 29th Street, 10th Floor | New York, NY 10016
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://kallyope.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/kallyope/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kallyope Presents Elismetrep Data for Acute Migraine at AHS
    Kallyope Presents Elismetrep Data for Acute Migraine at AHS

    04 Jun 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260604116888/en/Kallyope-Presents-New-Data-on-Novel-TRPM8-Channel-Blocker-Elismetrep-for-the-Acute-Treatment-for-Migraine-at-the-American-Headache-Society-68th-Annual-Scientific-Meeting

    BUSINESSWIRE
    04 Jun 2026
    Share Share
    Kallyope Presents Phase 2b Migraine Drug Data at AAN 2026
    Kallyope Presents Phase 2b Migraine Drug Data at AAN 2026

    22 Apr 2026

    // PRESS RELEASE

    https://kallyope.com/kallyopes-phase-2b-study-of-elismetrep-a-novel-approach-for-treating-migraine-presented-at-the-american-academy-of-neurology-annual-meeting/

    PRESS RELEASE
    22 Apr 2026
    Share Share
    Kallyope Reveals Strategy For Migraine & Metabolism Porrtfolio
    Kallyope Reveals Strategy For Migraine & Metabolism Porrtfolio

    07 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-07/kallyope-announces-2026-strategic-priorities-for-migraine-and-metabolism-portfolio-based-on-novel-ne

    PHARMIWEB
    07 Jan 2026
    Share Share
    Kallyope To Present At J.P. Morgan Healthcare Conference
    Kallyope To Present At J.P. Morgan Healthcare Conference

    17 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251217916671/en/Kallyope-To-Present-at-the-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    17 Dec 2025
    Share Share
    Kallyope Reports Positive Phase 2B Results For Elismetrep
    Kallyope Reports Positive Phase 2B Results For Elismetrep

    08 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-08/kallyope-announces-positive-results-from-phase-2b-study-of-elismetrep-for-the-acute-treatment-of-mig

    PHARMIWEB
    08 Dec 2025
    Share Share
    Crossroads Transforms Opioid Use Disorder Treatment
    Crossroads Transforms Opioid Use Disorder Treatment

    10 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240910844342/en

    BUSINESSWIRE
    10 Sep 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search